Welcome to the Afibber’s Forum
Serving Afibbers worldwide since 1999
Moderated by Shannon and Carey


Afibbers Home Afibbers Forum General Health Forum
Afib Resources Afib Database Vitamin Shop


Welcome! Log In Create A New Profile

Advanced

Rubidium trace mineral research

Posted by Richard 
Richard
Rubidium trace mineral research
October 20, 2003 02:45PM
Hello All,

In light of the conversation in the conference room on copper and zinc, and my peaked interest in regards to my hair analysis study, I started taking a closer look at a few of the minerals that I was low in. One was Rubidium (Rb), and my hair analysis values were extremely low. The other was Lithium, but my focus is on Rubidium, for now. There isn't much information out there on this trace element, but I did find some interesting studies at pubmed.com. Some of the info. went a bit over my head, but I'll post anyway, in case someone else picks up on something that I missed or didn't understand. I found the first one the most interesting.

The link between ion permeation and inactivation gating of Kv4 potassium channels.

Shahidullah M, Covarrubias M.

Department of Pathology, Anatomy and Cell Biology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.

Kv4 potassium channels undergo rapid inactivation but do not seem to exhibit the classical N-type and C-type mechanisms present in other Kv channels. We have previously hypothesized that Kv4 channels preferentially inactivate from the preopen closed state, which involves regions of the channel that contribute to the internal vestibule of the pore. To further test this hypothesis, we have examined the effects of permeant ions on gating of three Kv4 channels (Kv4.1, Kv4.2, and Kv4.3) expressed in Xenopus oocytes. Rb(+) is an excellent tool for this purpose because its prolonged residency time in the pore delays K(+) channel closing. The data showed that, only when Rb(+) carried the current, both channel closing and the development of macroscopic inactivation are slowed (1.5- to 4-fold, relative to the K(+) current). Furthermore, macroscopic Rb(+) currents were larger than K(+) currents (1.2- to 3-fold) as the result of a more stable open state, which increases the maximum open probability. These results demonstrate that pore occupancy can influence inactivation gating in a manner that depends on how channel closing impacts inactivation from the preopen closed state. By examining possible changes in ionic selectivity and the influence of elevating the external K(+) concentration, additional experiments did not support the presence of C-type inactivation in Kv4 channels.
[www.ncbi.nlm.nih.gov]

Gamma-hydroxybutyrate receptor function determined by stimulation of rubidium and calcium movements from NCB-20 neurons.

Kemmel V, Taleb O, Andriamampandry C, Aunis D, Maitre M.

Institut de Chimie Biologique and INSERM U-338, Faculte de Medecine, 11 rue Humann, 67085, Strasbourg Cedex, France.

Gamma-Hydroxybutyrate is derived from GABA in brain and plays specific functional roles in the CNS. It is thought to exert a tonic inhibitory control on dopamine and GABA release in certain brain areas, through specific gamma-hydroxybutyrate receptors. Apart from modifying certain calcium currents, the specific transduction mechanism induced by stimulation of gamma-hydroxybutyrate receptors remains largely unknown. We investigated the possible contribution of K(+) channels to the hyperpolarization phenomena generally induced by gamma-hydroxybutyrate in brain, by monitoring (86)Rb(+) movements in a neuronal cell line (NCB-20 cells), which expresses gamma-hydroxybutyrate receptors. Physiological concentrations of gamma-hydroxybutyrate (5-25 microM) induce a slow efflux of (86)Rb(+), which peaks at 5-15 min and returns to baseline levels 20 min later after constant stimulation. This effect can be reproduced by the gamma-hydroxybutyrate receptor agonist NCS-356 and blocked by the gamma-hydroxybutyrate receptor antagonist 6,7,8,9-tetrahydro-5-[H]-benzocycloheptene-5-ol-4-ylidene. The GABA(cool smiley receptor antagonist CGP 55845 has no effect on gamma-hydroxybutyrate-induced (86)Rb(+) efflux. The pharmacology of this gamma-hydroxybutyrate-dependent efflux of (86)Rb(+) is in favor of the involvement of tetraethylammonium and charybdotoxin insensitive, apamin sensitive Ca(2+) activated K(+) channels, identifying them as small conductance calcium activated channels. We demonstrated a gamma-hydroxybutyrate dose-dependent entry of calcium ions into NCB-20 neuroblastoma cells at resting potential. Electrophysiological data showed that this Ca(2+) entry corresponded mainly to a left-hand shift of the current/voltage relation of the T-type calcium channel. This process must at least partially trigger small conductance calcium activated channel activation leading to gamma-hydroxybutyrate-induced hyperpolarization.
[www.ncbi.nlm.nih.gov]

Aldosterone regulates the Na-K-2Cl cotransporter in vascular smooth muscle.

Jiang G, Cobbs S, Klein JD, O'Neill WC.

Renal Division, Department of Medicine, Emory University School of Medicine, Atlanta, Ga 30322, USA.

Aldosterone increases cation transport and contractility of vascular smooth muscle, but the specific transporter involved and how it is linked to smooth muscle tone is unknown. Because the Na-K-2Cl cotransporter (NKCC1) contributes to vascular smooth muscle contraction and is regulated by vasoactive compounds, we sought to determine whether this transporter is a target of aldosterone in rat aorta. Treatment of adrenalectomized rats with aldosterone for 7 days resulted in a 63% increase in NKCC1 activity as measured by bumetanide-sensitive efflux of 86Rb+. Treatment of normal aortas in culture with aldosterone for 3 and 7 days resulted in 29% and 47% increases in NKCC1 activity, respectively. Aldosterone had no acute effect on 86Rb+ efflux. Stimulation of NKCC1 was blocked by spironolactone, a mineralocorticoid receptor antagonist, but not by RU38486, a glucocorticoid receptor antagonist. Aldosterone did not augment the stimulation of NKCC1 by phenylephrine and did not increase NKCC1 mRNA as determined by real-time polymerase chain reaction. We conclude that aldosterone regulates the Na-K-2Cl cotransporter in vascular smooth muscle through classic mineralocorticoid receptors but not through changes in the abundance of NKCC1 mRNA. This could account for the increase in Na+, K+, and Cl- fluxes previously observed in vascular smooth muscle from mineralocorticoid-treated animals and may contribute to increased vascular tone.
[www.ncbi.nlm.nih.gov]

Intracellular Na+ regulates dopamine and angiotensin II receptors availability at the plasma membrane and their cellular responses in renal epithelia.

Efendiev R, Budu CE, Cinelli AR, Bertorello AM, Pedemonte CH.

College of Pharmacy, University of Houston, Houston, Texas 77204, USA.

The balance and cross-talk between natruretic and antinatruretic hormone receptors plays a critical role in the regulation of renal Na+ homeostasis, which is a major determinant of blood pressure. Dopamine and angiotensin II have antagonistic effects on renal Na+ and water excretion, which involves regulation of the Na+,K+-ATPase activity. Herein we demonstrate that angiotensin II (Ang II) stimulation of AT1 receptors in proximal tubule cells induces the recruitment of Na+,K+-ATPase molecules to the plasmalemma, in a process mediated by protein kinase Cbeta and interaction of the Na+,K+-ATPase with adaptor protein 1. Ang II stimulation led to phosphorylation of the alpha subunit Ser-11 and Ser-18 residues, and substitution of these amino acids with alanine residues completely abolished the Ang II-induced stimulation of Na+,K+-ATPase-mediated Rb+ transport. Thus, for Ang II-dependent stimulation of Na+,K+-ATPase activity, phosphorylation of these serine residues is essential and may constitute a triggering signal for recruitment of Na+,K+-ATPase molecules to the plasma membrane. When cells were treated simultaneously with saturating concentrations of dopamine and Ang II, either activation or inhibition of the Na+,K+-ATPase activity was produced dependent on the intracellular Na+ concentration, which was varied in a very narrow physiological range (9-19 mm). A small increase in intracellular Na+ concentrations induces the recruitment of D1 receptors to the plasma membrane and a reduction in plasma membrane AT1 receptors. Thus, one or more proteins may act as an intracellular Na+ concentration sensor and play a major regulatory role on the effect of hormones that regulate proximal tubule Na+ reabsorption.
[www.ncbi.nlm.nih.gov]

Binding of 1 Rb+ accelerates dephosphorylation of the Na+,K+-ATPase without leading to Rb+ occlusion.

Kaufman SB, Gonzalez-Lebrero RM, Garrahan PJ, Rossi RC.

Instituto de Quimica y Fisicoquimica Biologicas and Departamento de Quimica Biologica, Facultad de Farmacia y Bioquimica, Universidad de Buenos Aires, Junin 956, Argentina. sbkauf@qb.ffyb.uba.ar

In steady-state conditions and for concentrations of the K(+)-congener Rb(+) less than 2.5 mM, Rb(+)-dependent ATPase activity is significantly higher than the steady-state rate of breakdown of Rb(+)-occluded states, a discrepancy that disappears at sufficiently high [Rb(+)]. Direct experimental evidence is provided that supports the explanation that the binding of a single Rb(+) to the phosphoenzyme conformer E(2)P accelerates dephosphorylation without leading to the occlusion of the cation.
[www.ncbi.nlm.nih.gov]

A medium-throughput functional assay of KCNQ2 potassium channels using rubidium efflux and atomic absorption spectrometry.

Scott CW, Wilkins DE, Trivedi S, Crankshaw DJ.

Lead Discovery Department, AstraZeneca Pharmaceuticals LP, Wilmington, DE 19810, USA. clay.scott@astrazeneca.com

Heterologous expression of KCNQ2 (Kv7.2) results in the formation of a slowly activating, noninactivating, voltage-gated potassium channel. Using a cell line that stably expresses KCNQ2, we developed a rubidium flux assay to measure the functional activity and pharmacological modulation of this ion channel. Rubidium flux was performed in a 96-well microtiter plate format; rubidium was quantified using an automated atomic absorption spectrometer to enable screening of 1000 data points/day. Cells accumulated rubidium at 37 degrees C in a monoexponential manner with t(1/2)=40min. Treating cells with elevated extracellular potassium caused membrane depolarization and stimulation of rubidium efflux through KCNQ2. The rate of rubidium efflux increased with increasing extracellular potassium: the t(1/2) at 50mM potassium was 5.1 min. Potassium-stimulated efflux was potentiated by the anticonvulsant drug retigabine (EC(50)=0.5 microM). Both potassium-induced and retigabine-facilitated efflux were blocked by TEA (IC(50)s=0.4 and 0.3mM, respectively) and the neurotransmitter release enhancers and putative cognition enhancers linopirdine (IC(50)s=2.3 and 7.1 microM, respectively) and XE991 (IC(50)s=0.3 and 0.9 microM, respectively). Screening a collection of ion channel modulators revealed additional inhibitors including clofilium (IC(50) = 27 microM). These studies extend the pharmacological profile of KCNQ2 and demonstrate the feasibility of using this assay system to rapidly screen for compounds that modulate the function of KCNQ2.
[www.ncbi.nlm.nih.gov]

Evidence for tryptophan residues in the cation transport path of the Na(+),K(+)-ATPase.

Yudowski GA, Bar Shimon M, Tal DM, Gonzalez-Lebrero RM, Rossi RC, Garrahan PJ, Beauge LA, Karlish SJ.

Laboratorio de Biofisica, Instituto M. y M. Ferreyra, INIMEC-CONICET, 5000 Cordoba, Argentina.

A family of aryl isothiouronium derivatives was designed as probes for cation binding sites of Na(+),K(+)-ATPase. Previous work showed that 1-bromo-2,4,6-tris(methylisothiouronium)benzene (Br-TITU) acts as a competitive blocker of Na(+) or K(+) occlusion. In addition to a high-affinity cytoplasmic site (K(D) < 1 microM), a low-affinity site (K(D) approximately 10 microM) was detected, presumably extracellular. Here we describe properties of Br-TITU as a blocker at the extracellular surface. In human red blood cells Br-TITU inhibits ouabain-sensitive Na(+) transport (K(D) approximately 30 microM) in a manner antagonistic with respect to extracellular Na(+). In addition, Br-TITU impairs K(+)-stimulated dephosphorylation and Rb(+) occlusion from phosphorylated enzyme of renal Na(+),K(+)-ATPase, consistent with binding to an extracellular site. Incubation of renal Na(+),K(+)-ATPase with Br-TITU at pH 9 irreversibly inactivates Na(+),K(+)-ATPase activity and Rb(+) occlusion. Rb(+) or Na(+) ions protect. Preincubation of Br-TITU with red cells in a K(+)-free medium at pH 9 irreversibly inactivates ouabain-sensitive (22)Na(+) efflux, showing that inactivation occurs at an extracellular site. K(+), Cs(+), and Li(+) ions protect against this effect, but the apparent affinity for K(+), Cs(+), or Li(+) is similar (K(D) approximately 5 mM) despite their different affinities for external activation of the Na(+) pump. Br-TITU quenches tryptophan fluorescence of renal Na(+),K(+)-ATPase or of digested "19 kDa membranes". After incubation at pH 9 irreversible loss of tryptophan fluorescence is observed and Rb(+) or Na(+) ions protect. The Br-TITU appears to interact strongly with tryptophan residue(s) within the lipid or at the extracellular membrane-water interface and interfere with cation occlusion and Na(+),K(+)-ATPase activity.
[www.ncbi.nlm.nih.gov]

Tight coupling of rubidium conductance and inactivation in human KCNQ1 potassium channels.

Seebohm G, Sanguinetti MC, Pusch M.

Department of Physiology, University of Utah, Salt Lake City, UT USA, Physiologisches Institut I, Tubingen, Germany.

KCNQ1 K+ channels in humans are important for repolarization of cardiac action potentials and for K+ secretion in the inner ear. The pore-forming channel subunits form heteromeric complexes with small regulatory subunits of the KCNE family, in particular with KCNE1 to form channels that conduct a slow delayed rectifier K+ current, IKs. This association leads to alteration of biophysical properties, including a slowing of activation, a suppression of inactivation and an increase of the apparent single-channel conductance. In addition, inward Rb+ currents conducted by homomeric KCNQ1 channels are about threefold larger than K+ currents, whereas heteromeric KCNQ1-KCNE1 channels have smaller inward Rb+ currents compared to K+ currents. We determined inactivation properties and compared K+ vs. Rb+ inward currents for channels formed by co-assembly of KCNQ1 with KCNE1, KCNE3 and KCNE5, and for homomeric KCNQ1 channels with point mutations in the pore helix S5 or S6 transmembrane domains. Several of the channels with point mutations eliminated the apparent inactivation of KCNQ1, as described previously (Seebohm et al. 2001). We found that the extent of inactivation and the ratio of Rb+/K+ currents were positively correlated. Since the effect of Rb+ on the current size has been shown previously to be related to a fast 'flickery' process, our results suggest that inactivation of KCNQ1 channels is related to a fast flicker of the open channel. A kinetic model incorporating two open states, no explicit inactivated state and a fast flicker that is different for the two open states is able to account for the apparent inactivation and the correlation of inactivation and large Rb+ currents. We conclude that an association between KCNQ1 and KCNE subunits or removal of inactivation by mutation of KCNQ1 stabilizes the open conformation of the pore principally by altering an interaction between the pore helix and the selectivity filter and with S5/S6 domains.
[www.ncbi.nlm.nih.gov]

Richard
Mike F. V42
Re: Rubidium trace mineral research
October 20, 2003 09:50PM
Richard,

Jeez dude.... you comprehensively out-braincramped ANY of PC's valued offerings with THAT little lot!!

I do, however, have a LOT of time (and respect) for your take on tackling AF and other palps on the basis of looking at what is and is not going on RIGHT at ground level - i.e. at the molecular level. It sure seems like AF is a complicated beast indeed, and looking at things in this degree of intricate (and for most of us here massively braincramping) detail. It could well be that AF is ONE possible outcome of a subtle combination of various mineral inbalances brought about as a result of our increasingly un-nutritious twentieth and now twenty-first century diets. Maybe those of us with GERD and other upper digestive tract problems simply exacerbate this problem by way of malabsorption of some key minerals and nutrients.

BTW, how would you rate fecal testing as a way of assessing mineral status? I had one done in the US by Docter's Data Inc. which amongst other things revealed that my platinum levels were off the scale/100th percentile/0.052 as against range up to 0.003. (Bismuth, tungsten were also well below average, and I had no berrylium whatsoever........ whatever that means!).) I can't find anything much relating to platinum levels and I've no idea why it's so high..... unless it's originating from my gold-palladium alloy fillings (installed to replace amalgums 4 years ago - not done properly unfortunately (I had it done cos the existing amalgums were shot and I 'fancid' the gold).

Cheers for now and keep up the good work,

Mike F.
J. Pisano
Re: Rubidium trace mineral research
October 21, 2003 12:02AM
Richard,

It looks as though rubidium research is indeed scare. Rubidium is not yet classified as an essential element for nutrition. I did find some information that you may find helpful. Most of this is based from Staying Healthy with Nutrition: The Complete Guide to Diet and Nutritional Medicine by Elson M. Haas M.D.... It is interesting that that Rb can be substituted for K and that they might act as an atagonist to each other....

Rubidium is found in the rocks and seawater as well as the human body, which normally contains about 350 mg. Rubidium is not yet considered essential. Rubidium is chemically similar to potassium and while some animals can use it instead of potassium for certain functions, this is not known to be true for humans. Rubidium might be a potassium antagonist for absorption and utilization.

Rubidium absorption via the intestines is about 90% and it is found spread throughout the body, with the lowest level in bone and dental tissue. Any extra rubidium is eliminated primarily by the kidneys.

Sources: Food sources of rubidium are not well researched. Some fruits and vegetables have about 35 ppm. Rubidium may also be in some waters. Rubidium supplements are available through Remission Foundation both as pills and a liquid.

Functions: No essential functions of rubidium are known yet. In studies with mice, rubidium decreases tumor growth, perhaps by replacing potassium in cellular transport systems or by attaching to cancer cell membranes. Rubidium is extremely alkalizing. Rubidium may have a tranquilizing or hypnotic effect in some animals and humans.

Uses: There are no mainstream uses for rubidium yet. Its tranquilizing effect could help in the treatment of nervous disorders and epilepsy. It has been used for alkalizing in cancer support and research.

Deficiency and toxicity: Rubidium deficiency and toxicity are not well understood. Rubidium deficiency depresses growth and life expectancy in goats. Rubidium deficiency may increase cancer.

Requirements: There is no RDA for rubidium. The average dietary intake could be around 1.5 mg per day (typical range 1 to 5 mg). Rubidium is higher in certain foods including coffee, black tea, fruits, vegetables (particularly asparagus), poultry and fish. Rubidium is typically high in volcanic soils. (Dr. A. Keith Brewer, High pH Cancer Therapy With Cesium, page 17)
Richard
Re: Rubidium trace mineral research
October 21, 2003 02:41AM
Mike and Joe,

Mike, that was very interesting about the palladium and platinum. My platinum levels were .003 with a ref range of <.005, so I was alright there, but if I remember correctly, my palladium levels were high. I have had two hair analysis done, and the first one, that I believe showed palladium, was given to Dr. Gersten, and I failed to keep a copy, so I must get that. I, too, have two gold crowns, and have begun the removal of my amalgams. I would be very interested in seeing all your results of your test, if you don't mind sharing, so I can compare with mine, even though mine was via hair. I'll post my results, as well. Yes, I agree, that the above are brain crampers, indeed, and from Joe's post, it would seem that Rb competes with K, which I did not know. Thanks, Joe, for the post. I was under the assumption that Rb helped K. FWIW, I found an MIT site, that compares the thermal and electrical conductivity of the different elements. It seems that Cu has the most conductivity. That makes sense, since Cu is used in electrical wiring. It was interesting to look at the different conductivites, however, and Rb was up there. Here's the site, and when you get there, if you so desire, just change the name of the element in the address field at the top, and you can look at all the minerals.
[www-tech.mit.edu]

I'm not sure if I'm getting closer to the top of the hole, or digging the hole deeper, but I'll keep searching, anyway.

Richard
Mike F. V42
Re: Rubidium trace mineral research
October 21, 2003 03:21AM
Richard,

Results of Fecal testing Potentially Toxic Metals Profile - Doctor's Data Inc, Illinois, 12th Oct 2002

Hg - 0.125 (mg/kg) - ref <0.05 WITHOUT amalgums........ so high given my lack of amalgums
Antimony - 0.071 - ref <0.08
Arsenic - 0.35 - ref <0.3 - a little high
Beryllium - 0.0 - ref <0.009
Bismuth - 0.009 - ref <0.05
Cadmium - 0.44 - ref <0.5
Copper - 39 - ref <60
Lead - 0.64 - ref <0.5
Nickel - 5.5 - ref <8.0
Platinum - 0.052 - ref <0.003 - VERY HIGH
Thallium - 0.028 - ref <0.02 - a little high
Tungsten - 0.027 - ref <0.09
Uranium - 0.022 - ref <0.12

Cheers,

Mike F.
J. Pisano
Re: Rubidium trace mineral research
October 21, 2003 06:39AM
Richard,

First glance of the literature on lithium deficiency poses some interesting thoughts.... Lithium deficiency is helped by Mg which acts as a synergist... hmmmmmmmm...that sounds interesting. Much of the studies show lithium deficiency related to agressivness and bi-polarism and ADD. Also, as almost everything is, lithium deficiency is aggravated by high sugar consumption.... fwiw.......

Joe
Richard
Re: Rubidium trace mineral research
October 21, 2003 10:32AM
Thanks Joe, for that bit of info. My wife always says I have ADD, so there could be a connection. Don't tell her, but I have ADD when I hear the "honey do" thing. I did cut out sugar consumption about 10 mths. ago, with an occasional cheat, and I mean occasional. I think I'm going to start taking a trace mineral supplement, when I find a good one. I'll pose Rb and Li to Dr. Gersten, and see what he says.

Richard
Sorry, only registered users may post in this forum.

Click here to login